Can Fite Biopharma Ltd (CANF) Stock Price, Quote, News & History

CANFAMEX
$2.91
N/A
At close: Apr 24, 5:00 PM EST
$2.92
0.00520.18%
After Hours: 7:46 PM EST

Financials

Quarterly
Annual
Name
Revenue
Change
Gross
Change
EBITDA
Change
EBIT
Change
Earnings
Change

Cash Flows

Operating Cash Flow (TTM)
-8.95M
Investing Cash Flow (TTM)
-2.00K
Financing Cash Flow (TTM)
9.64M
Free Cash Flow (TTM)
-8.95M
Capital Expenditure (TTM)
-2.00K
Net Change in Cash (TTM)
693.00K

Analyst Trends and Forecast

2
Nov 25
1
Dec 25
Buy
Hold
Sell
Strong Sell

Analyst Rating and Forecast

12345
4.0
Buy
Strong Buy
Buy
Hold
Sell
Strong Sell

Valuation Metrics

Enterprise Value
-$1.52M
PE Ratio (TTM)
-
PE Ratio (FWD)
-
PEG Ratio (TTM)
-
PS Ratio (TTM)
6.57
PB Ratio (TTM)
1.11
Earnings Yield % (TTM)
-369.28%
Earnings Yield % (FWD)
-71.13%
EV / EBITDA (TTM)
-
Price / EBITDA (TTM)
-
Price / Free Cash Flow (TTM)
-
Book Value / Share
$2.61

Company Debt

Total Debt
-
LT Debt
-
LT Debt Issuance (TTM)
-
LT Debt Repayment (TTM)
-
Total Cash
$5.53M
Debt to Equity
0.01
Issuance of Debt (TTM)
-
Repayment of Debt (TTM)
-

Key Statistics

Open
$2.97
Close
$2.91
Volume / Avg.
18.52K / 679.10K
Day Range
$2.88 - $3.04
52 Wk Range
2.87 - 3.62K
Market Cap
$6.25M
P/E Ratio
-
Dividend Yield
-
Exchange
AMEX
RSI
24
Short Interest
1.76%
Days to Cover
1

About

Sector
Health Care
Industry
Biotechnology
Can Fite Biopharma Ltd is a clinical-stage biopharmaceutical company. The company focuses on developing orally bioavailable small-molecule drugs targeting the A3 adenosine receptor for treating cancer, inflammatory diseases, liver disorders, and rela...
Show More
Edge Rankings

Stock Score Locked: Want to See it?

Benzinga Rankings give you vital metrics on any stock – anytime.

Reveal Full Score

Compare

EPS worse than industry
Earnings Per Share
EPS is the portion of a company's profit allocated to each outstanding share of common stock. It is a key metric for investors to assess a company's profitability.

FAQ

Q

How do I buy Can Fite Biopharma (CANF) stock?

A

You can purchase shares of Can Fite Biopharma (AMEX:CANF) through any online brokerage.

View our list of the best stock brokerages

Q

Who are Can Fite Biopharma (CANF) competitors?

A

There are no as such competitors for Can Fite Biopharma.

Q

What is the forecast, or price target, for Can Fite Biopharma (CANF) stock?

A

Can Fite Biopharma has a consensus price target of $10.17.

Q

What is the current price for Can Fite Biopharma (CANF)?

A

The stock price for Can Fite Biopharma (AMEX: CANF) is $2.9152 last updated April 24, 2026 at 7:46 PM EDT.

Q

Does Can Fite Biopharma (CANF) pay a dividend?

A

There are no upcoming dividends for Can Fite Biopharma.

Q

When is Can Fite Biopharma (AMEX:CANF) reporting earnings?

A

Can Fite Biopharma does not have any upcoming earnings scheduled.

Q

Is Can Fite Biopharma (CANF) going to split?

A

There is no upcoming split for Can Fite Biopharma.

Q

What sector and industry does Can Fite Biopharma (CANF) operate in?

A

Can Fite Biopharma is in the Health Care sector and Biotechnology industry. They are listed on the AMEX.